F
Ford Motor Company
F has the edge over PHM overall, supported by stronger valuation and stronger modeled upside.
PHM
PulteGroup, Inc.
PHM trails on the overall score without a compensating advantage in the available component scores.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
PHM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
PHM's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
PHM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.8x | $54.71 | -57% |
| Fair | 8.8x | $82.04 | -35% |
| Expensive | 11x | $99.83 | -21% |
| Current | 14x | $127 | — |
| Forward | 14x | $127 | — |
Historical ranges are pointers, not guarantees.
PHM's PE is in its expensive range at 13.6x. On analysts' estimates for next year's earnings, today's price would be 13.7x.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
F has the edge over PHM on the outlook, with more favorable earnings and profitability expectations.
PHM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PHM's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
PHM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.29 | -0.7% |
| Q3 2026 | $9.36 | -28% |
| Q2 2026 | $9.79 | -27% |
| Q1 2026 | $10.34 | -27% |
| Q4 2025 | $11.12 | -24% |
| Q3 2025 | $12.97 | -4.2% |
| Q2 2025 | $13.36 | +2.1% |
| Q1 2025 | $14.16 | +14% |
| Q4 2024 | $14.69 | +25% |
PHM has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over PHM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
PHM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | -9.8% |
| Q2 2026 | $4B | -9.6% |
| Q1 2026 | $3.4B | -12% |
| Q4 2025 | $4.6B | -6.3% |
| Q3 2025 | $4.4B | -1.6% |
| Q2 2025 | $4.4B | -4.3% |
| Q1 2025 | $3.9B | -1.4% |
| Q4 2024 | $4.9B | +15% |
PHM's revenue has slid since its 2022 peak: $4B last quarter, down 9.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -2.7 points |
| Q1 2026 | 13% | -4.3 points |
| Q4 2025 | 14% | -9.8 points |
| Q3 2025 | 17% | -2.8 points |
| Q2 2025 | 18% | -4.5 points |
| Q1 2025 | 18% | -4.5 points |
| Q4 2024 | 24% | +2 points |
PHM has the edge over F on profitability, with a higher operating margin.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over PHM on cash flow, with more consistent year-over-year improvement.
PHM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $437.2M | -33% |
| Q2 2026 | -$12.9M | -105% |
| Q1 2026 | $134.4M | +28% |
| Q4 2025 | $739.8M | +36% |
| Q3 2025 | $651.1M | +56% |
| Q2 2025 | $253M | -35% |
| Q1 2025 | $104.6M | -51% |
| Q4 2024 | $543.1M | +106% |
PHM still generates free cash flow, though less than at its 2022 peak: $1.3B over the past year.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
PHM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -2.7M shares |
| 1 year | -5.2% | -10.3M shares |
| 3 years | -14% | -31.8M shares |
| 5 years | -27% | -71.1M shares |
| Available history | -31% | -83.6M shares |
PHM has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $350.4M |
| Q2 2026 | $373M |
| Q1 2026 | $308.2M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q2 2025 | $300M |
| Q1 2025 | $300M |
| Q4 2024 | $320M |
PHM spent $1.3B buying back its own shares over the past year, up 9.1% from the year before.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over PHM on leverage, with a lower net debt burden relative to earnings.
PHM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.4x | Net Cash |
PHM's net debt is less than a year of its operating earnings (EBITDA).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
PHM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 66.1 | Neutral |
PHM's weekly RSI is 53 (neutral) and its Stochastic is 66 (neutral).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
PHM PE vs Consumer Cyclical Sector
| Metric | PHM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 25% below |
| PE % | 99 | 47 | 52 pts above |
PHM is trading at 14x earnings, a 25% discount to the Consumer Cyclical sector's median of 18x.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
PHM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $120.8 | 5% above |
| 20 week MA | $124.3 | 2.1% above |
| 50 week MA | $124.4 | 2% above |
| 100 week MA | $118.8 | 6.8% above |
| 200 week MA | $107.7 | 18% above |
PHM has the edge over F on trend strength, trading above more of its moving averages.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.
PHM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.8 | $45.2 | +17% |
| 2021 | $45.2 | $54.7 | +21% |
| 2022 | $54.7 | $45.8 | -16% |
| 2023 | $45.8 | $103.2 | +125% |
| 2024 | $103.2 | $109.5 | +6.1% |
| 2025 | $109.5 | $119.2 | +8.8% |
| 2026 YTD | $119.2 | $126.9 | +6.5% |
PHM has the edge over F on returns for 2026, with the stronger performance.